Aperio Group’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $56M | Sell |
136,592
-2,888
| -2% | -$1.2M | 0.17% | 110 |
|
|
2020
Q3 | $57.7M | Sell |
139,480
-1,106
| -0.8% | -$445K | 0.2% | 93 |
|
|
2020
Q2 | $54.5M | Sell |
140,586
-10,070
| -7% | -$3.77M | 0.2% | 94 |
|
|
2020
Q1 | $47.3M | Buy |
150,656
+8,988
| +6% | +$3.03M | 0.21% | 87 |
|
|
2019
Q4 | $51.9M | Buy |
141,668
+6,245
| +5% | +$1.98M | 0.19% | 110 |
|
|
2019
Q3 | $34.6M | Buy |
135,423
+15,708
| +13% | +$4.4M | 0.14% | 171 |
|
|
2019
Q2 | $31.8M | Sell |
119,715
-15,294
| -11% | -$3.88M | 0.13% | 171 |
|
|
2019
Q1 | $35.9M | Buy |
135,009
+1,103
| +0.8% | +$318K | 0.16% | 144 |
|
|
2018
Q4 | $38.4M | Sell |
133,906
-15,876
| -11% | -$5.03M | 0.19% | 110 |
|
|
2018
Q3 | $50.7M | Buy |
149,782
+2,467
| +2% | +$802K | 0.22% | 94 |
|
|
2018
Q2 | $43.8M | Buy |
147,315
+11,701
| +9% | +$3.43M | 0.21% | 102 |
|
|
2018
Q1 | $36.5M | Buy |
135,614
+1,958
| +1% | +$530K | 0.18% | 123 |
|
|
2017
Q4 | $33.2M | Buy |
133,656
+1,439
| +1% | +$355K | 0.17% | 135 |
|
|
2017
Q3 | $32.2M | Buy |
132,217
+25,646
| +24% | +$6.28M | 0.18% | 123 |
|
|
2017
Q2 | $25.6M | Buy |
106,571
+20,614
| +24% | +$4.67M | 0.16% | 148 |
|
|
2017
Q1 | $17.7M | Buy |
85,957
+5,165
| +6% | +$1.07M | 0.12% | 199 |
|
|
2016
Q4 | $16.5M | Buy |
80,792
+11,198
| +16% | +$2.14M | 0.13% | 186 |
|
|
2016
Q3 | $12.3M | Buy |
69,594
+2,018
| +3% | +$350K | 0.09% | 266 |
|
|
2016
Q2 | $12.2M | Buy |
67,576
+4,106
| +6% | +$729K | 0.1% | 247 |
|
|
2016
Q1 | $11.6M | Buy |
63,470
+9,052
| +17% | +$1.57M | 0.1% | 243 |
|
|
2015
Q4 | $9.71M | Sell |
54,418
-966
| -2% | -$170K | 0.09% | 262 |
|
|
2015
Q3 | $9.91M | Buy |
55,384
+2,747
| +5% | +$508K | 0.1% | 235 |
|
|
2015
Q2 | $10.1M | Buy |
52,637
+5,435
| +12% | +$1.01M | 0.1% | 241 |
|
|
2015
Q1 | $8.4M | Buy |
47,202
+5,030
| +12% | +$796K | 0.09% | 262 |
|
|
2014
Q4 | $6.06M | Buy |
42,172
+3,292
| +8% | +$450K | 0.07% | 322 |
|
|
2014
Q3 | $5.07M | Buy |
38,880
+2,395
| +7% | +$304K | 0.07% | 356 |
|
|
2014
Q2 | $4.66M | Buy |
36,485
+2,054
| +6% | +$243K | 0.07% | 356 |
|
|
2014
Q1 | $3.88M | Buy |
+34,431
| New | +$3.59M | 0.05% | 453 |
|
|
2013
Q4 | – | Sell |
-26,142
| Closed | -$2.56M | – | 460 |
|
|
2013
Q3 | $2.44M | Buy |
26,142
+3,708
| +17% | +$340K | 0.05% | 507 |
|
|
2013
Q2 | $1.89M | Buy |
+22,434
| New | +$1.77M | 0.05% | 520 |
|
Other funds holding HUM
Aperio Group's HUM Position: Q4 2020 in Review
Aperio Group reduced its Humana (HUM) stake by 2.1% in Q4 2020, selling an estimated $1.2M and leaving 136,592 shares worth $56M. The position accounts for 0.17% of the portfolio, ranked #110.
Aperio Group first reported a position in HUM in Q2 2013 and has held it in 30 quarters since. The position peaked at $57.7M in Q3 2020. 868 funds tracked by Wall St. Rank hold HUM as of Q4 2020.
- Aperio Group held 136,592 shares of Humana worth $56M as of Q4 2020.
- Aperio Group sold 2,888 Humana shares in Q4 2020, an estimated $1.2M.
- Humana made up 0.17% of Aperio Group's portfolio in Q4 2020, its #110 holding.
- Aperio Group first reported a position in Humana in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Humana position peaked at $57.7M in Q3 2020.
- 868 funds tracked by Wall St. Rank held Humana as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.